Adelaide Research & Scholarship: Search

Search

Results 1-10 of 24 (Search time: 0.003 seconds).

previous
1
2
3
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2015	Detection and clinical significance of circulating tumor cells in colorectal cancer - 20 years of progress	Hardingham, J.; Grover, P.; Winter, M.; Hewett, P.; Price, T.; Thierry, B.
	2014	The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17	Sommeijer, D.; Karapetis, C.; Zalcberg, J.; Tu, D.; Jonker, D.; Simes, J.; Tebbutt, N.; Yip, D.; Price, T.; O'Callaghan, C.
	2015	Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature	Chan, D.; Pavlakis, N.; Shapiro, J.; Price, T.; Karapetis, C.; Tebbutt, N.; Segelov, E.; Rosell, R.
	2013	Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC clinical trials group and AGITG co.	Siu, L.; Shapiro, J.; Jonker, D.; Karapetis, C.; Zalcberg, J.; Simes, J.; Couture, F.; Moore, M.; Price, T.; Siddiqui, J.; Nott, L.; Charpentier, D.; Liauw, W.; Sawyer, M.; Jefford, M.; Magoski, N.; Haydon, A.; Walters, I.; Ringash, J.; Tu, D.; et al.
	2013	The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors	Rosen, L.; Lipton, L.; Price, T.; Belman, N.; Boccia, R.; Hurwitz, H.; Stephenson Jr, J.; Wirth, L.; McCoy, S.; Hei, Y.; Hsu, C.; Tebbutt, N.
	2015	Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer	Price, T.; Bruhn, M.; Lee, C.; Hardingham, J.; Townsend, A.; Mann, K.; Simes, J.; Weickhardt, A.; Wrin, J.; Wilson, K.; Gebski, V.; Van Hazel, G.; Robinson, B.; Cunningham, D.; Tebbutt, N.
	2013	Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy	Padman, S.; Padbury, R.; Beeke, C.; Karapetis, C.; Bishnoi, S.; Townsend, A.; Maddern, G.; Price, T.
	2014	Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia	Hocking, C.; Broadbridge, V.; Karapetis, C.; Beeke, C.; Padbury, R.; Maddern, G.; Roder, D.; Price, T.
	2013	Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors	Clarke, S.; Karapetis, C.; Gibbs, P.; Pavlakis, N.; Desai, J.; Michael, M.; Tebbutt, N.; Price, T.; Tabernero, J.
	2012	Biologic therapies in the metastatic colorectal cancer treatment continuum - applying current evidence to clinical practice	Peeters, M.; Price, T.